{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.1915T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "C",
            "alt": "T",
            "position": "1915"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "639"
          },
          "Description in input context": "dLRRK(I1915T)"
        },
        {
          "HGVS": "NM_001126112.3:c.2019G",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "G",
            "position": "2019"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "G",
            "position": "673"
          },
          "Description in input context": "hLRRK2(G2019S)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005138"
  },
  "Experiment Method": [
    {
      "Assay Method": "EGFP Reporter Assay",
      "Material used": {
        "Material Source": "Drosophila model",
        "Material Name": "Drosophila with EGFP reporter",
        "Description": "Reporter construct with let-7-binding sites in 3′UTR was used to measure miRNA pathway activity."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.1915T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Enhanced miRNA pathway suppression",
          "Result Description": "Pathogenic variants increased reporter expression compared to wild-type."
        },
        {
          "Variant": "NM_001126112.3:c.2019G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Enhanced miRNA pathway suppression",
          "Result Description": "Pathogenic variants increased reporter expression compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Reporter expression within baseline range (no significant change).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Reporter expression increased by ≥20% compared to baseline.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "No"
      }
    },
    {
      "Assay Method": "RNAi and Transgenic Expression",
      "Material used": {
        "Material Source": "Drosophila model",
        "Material Name": "RNAi constructs and transgenic lines",
        "Description": "RNAi-mediated knockdown and transgenic overexpression were used to assess LRRK2 function."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.1915T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered miRNA pathway activity",
          "Result Description": "Pathogenic variants disrupted miRNA pathway regulation."
        },
        {
          "Variant": "NM_001126112.3:c.2019G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered miRNA pathway activity",
          "Result Description": "Pathogenic variants disrupted miRNA pathway regulation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No significant change in miRNA pathway activity.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant alteration in miRNA pathway activity.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "No"
      }
    }
  ]
}